Advancing CART therapy for acute myeloid leukemia: recent breakthroughs and strategies for future development Front Immunol
A human genome editing-based MLL::AF4 B-cell ALL model recapitulates key cellular and molecular leukemogenic features Blood
Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors Mol Cancer
CARD11 gain of function upregulates BCL2A1 and promotes resistance to targeted therapies combination in B-cell lymphoma Blood
A complex interplay between H2A.Z and HP1 isoforms regulates pericentric heterochromatin Front Cell Dev Biol
Formation of an invasion-permissive matrix requires TGFβ/SNAIL1-regulated alternative splicing of fibronectin Breast Cancer Res